Your browser doesn't support javascript.
loading
The prognostic significance of [18F]FDG PET/CT in multiple myeloma according to novel interpretation criteria (IMPeTUs).
Sachpekidis, Christos; Merz, Maximilian; Raab, Marc-Steffen; Bertsch, Uta; Weru, Vivienn; Kopp-Schneider, Annette; Jauch, Anna; Goldschmidt, Hartmut; Dimitrakopoulou-Strauss, Antonia.
Afiliação
  • Sachpekidis C; Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69210, Heidelberg, Germany. c.sachpekidis@dkfz-heidelberg.de.
  • Merz M; Department of Hematology and Cell Therapy, University of Leipzig, Leipzig, Germany.
  • Raab MS; Department of Internal Medicine V, University Hospital Heidelberg and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Bertsch U; Department of Internal Medicine V, University Hospital Heidelberg and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Weru V; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Kopp-Schneider A; Department of Internal Medicine V, University Hospital Heidelberg and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Jauch A; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Goldschmidt H; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Dimitrakopoulou-Strauss A; Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany.
EJNMMI Res ; 11(1): 100, 2021 Oct 09.
Article em En | MEDLINE | ID: mdl-34628525

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article